1.
|
Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: KMU-IRB00003151, VGHKS95-CT3-11, NCT00656968
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: MSKCC-8082, NCI-T83-1374D, T83-1374
|
|
3.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 20 and over
Sponsor: Other
Protocol IDs: JMTO PREV07-01, UMIN000000776, NCT00508690
|
|
4.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: NCI, Other
Protocol IDs: CPPDM95-084, P30CA016672, MDA-CPPDM-95084, NCI-T95-0003D, CDR0000064361, T95-0003, NCT00002682
|
|
5.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-9703, S9703
|
|
6.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EORTC-20961, CRC-EORTC-20961, HOVON-33, NCT00003151
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: CAN-OTT-9008, NCI-V91-0084
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-787801
|
|
9.
|
Phase: Phase II
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ML21308, 2007-002895-32, NCT00642473
|
|
10.
|
Phase: No phase specified
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-7811
|
Mobile | Español
